机译:自体移植后霍奇金疾病常规监测成像的效用:单一机构的经验
University of Kansas Medical Center Kansas City KS USA;
University of Kansas Medical Center Kansas City KS USA;
University of Kansas Medical Center Kansas City KS USA;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Division of Hematologic MalignanciesCellular Therapeutic (HMCT) University of Kansas Medical Center;
Autologous stem cell transplant; Hodgkin disease; Surveillance scans; Survival;
机译:自体移植后霍奇金疾病常规监测成像的效用:单一机构的经验
机译:常规监测实验室检测在第一次缓解中检测患者复发检测中的效用:大型单机构研究的结果
机译:用于治疗复发/难治儿科,青少年和年轻成人霍奇金淋巴瘤的自体造血细胞移植:单一的制度经验
机译:高剂量素母蛋白和自体干细胞移植(HDM / SCT)用于治疗Al淀粉样症:十年单一制度经验
机译:自然杀手细胞回收和疾病结果在多发性骨髓瘤中的自体干细胞移植后
机译:难治性和复发性霍奇金淋巴瘤伴自体干细胞移植的结果:单一机构的经验。
机译:在疾病过程早期进行大剂量化学疗法和自体造血细胞移植似乎可以改善患者T细胞非霍奇金淋巴瘤的结果:单机构经验的结果